People · Operator
Named in public records as an officer, director or promoter · active 2012–2015 · Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Illumagear, Inc. | — | Other Technology | Seed | $6.6M | $85.2M | 2012 |
| Tansna Therapeutics, Inc. | — | Biotechnology | Pre-Seed | $850K | $1.1M | — |
Max Baker at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Max Baker on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Charles Bolten | 1 | 10 |
| ALAN MACINNES | 1 | 2 |
| Robert Karr | 1 | 2 |
| Kenneth Pilcher | 1 | 1 |
| John Maxwell Baker | 1 | 1 |
| Peter Maxwell Kuttel | 1 | 1 |
| Darren Maxwell Bechtel | 1 | 1 |
| Ken Maxwell Pilcher | 1 | 1 |
| George Capps | 1 | 1 |
| Kathleen Beckmann | 1 | 1 |
| Rajesh Devraj | 1 | 1 |
| Andrew Royal | 1 | 1 |
| Peter Kuttel | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.